Stay updated with breaking news from Accessed june. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA advisory committee voted against recommending a psychedelic treatment for PTSD, citing insufficient data for what many described as a still-promising path forward.The Psychopharmacologic Drugs Advisory Committee met June 4 to discuss a new drug application for midomafetamine (MDMA) — submitted by Lykos Therapeutics, formerly MAPS Public Benefit Corporation. It was the first FDA ....
Results suggest certain peroxiredoxins may be viable prognostic markers in glomerulopathies, including IgA nephropathy and membranous nephropathy. ....